Increase in research activities across the globe along with rising government funding to drive the growth of global proteomics market.
According to TechSci Research report, “Global Proteomics Market By Application (Clinical Diagnostic, Drug Discovery, Diagnostic Biomarker Discovery, Others), By Indication (Oncology, Infectious Disease, Respiratory, Cardiology, Others), By Technology (Conventional, Advanced, Quantitative, High-throughput, Bioinformatic Analysis), By Type (Expression, Functional, Structural, Computational), By Product (Reagents and Assays, Instruments, Software & Services), By End-User (Pharmaceutical and Biotechnology Companies, Research Institutes, CROs), By Region, Competition, Forecast & Opportunities, 2026F”, global proteomics market is expected to grow at an impressive CAGR of 17.12% during the forecast period and was valued at USD24.26 billion in 2020. Growing application of proteomics in discovery of new drugs is one of the major factor accounting for the growth of global proteomics market. Moreover, use of proteomics during the development of personalized medicines is further expected to bode well for the growth of global proteomics through the forecast years. In addition to this, rising awareness pertaining to the benefits of personalized medicines, is leading to increased expense in research activities for the development of proteomics by the leading companies as well as government organizations which in turn is expected to positively influence the growth of global proteomics market over the years to come. Also, identification of potential new drugs for the treatment of several diseases such as genetic disorders, birth disorders, among others is making headway for the growth of global proteomics market across the globe. However, there are some factors that can act as major impediments to the growth of global proteomics market through 2026 such as lack of skilled professionals and high cost of instruments.
Browse 207 Figures spread through110 Pages and an in-depth TOC on “Global Proteomics Market”
https://www.techsciresearch.com/report/proteomics-market/4559.html
Global proteomics market can be segmented based on application, indication, technology, type, product, end-user, company and region. Considering the end-user, the market is fragmented into pharmaceutical and biotechnology companies, research institutes and, CROs. The pharmaceutical and biotechnology companies segment dominated the global proteomics market in terms of largest market size until 2020. Additionally, requirement for protein therapeutics, including hormones, vaccines, monoclonal antibodies, among others is further aiding the growth of the segment through 2026. In terms of product, the market is fragmented into reagents and assays, instruments, software & services. Out of which, the reagents and assays segment is dominating the market and will maintain its lead during the forecast period, which can be accredited to their routine adoption in proteomics protocols.
Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Waters Corporation, Bio-Rad Laboratories, Inc., Danaher Corporation (SCIEX), GE Healthcare, Inc., PerkinElmer, Inc., Becton, Dickinson and Company, Illumina, Inc., Biocon Limited, Qiagen N.V., Bruker Corporation, Luminex Corporation, Evotec SE, Horiba, Ltd., Creative Proteomics, Promega Corporation, CellCarta Precision Medicine, Inc., Bioproximity LLC, Applied Biomics, Inc., are among others are the leading players operating in global proteomics market. The players are adopting several growth strategies to stay competitive in the global proteomics market. Other competitive strategies include mergers & acquisitions to diverse their product portfolio in order to strengthen their market position.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=4559
Customers can also request for 10% free customization on this report.
“North America is forecast to dominate the global proteomics market during the next 5 years on account of presence of major market players in the region. Moreover, growing expenditure on the development of structure-based drug designs coupled with increasing research in the fields of proteomics is also expected to contribute to the growing trend. Furthermore, Asia-Pacific is forecast to register high growth through 2026 due to growing biotechnology research, and rising awareness on personalized therapeutics in the region. Furthermore, need for high-quality research tools for data reproducibility is further expected to boost the market growth in Asia-Pacific region until 2026.”, said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
“Global Proteomics Market By Application (Clinical Diagnostic, Drug Discovery, Diagnostic Biomarker Discovery, Others), By Indication (Oncology, Infectious Disease, Respiratory, Cardiology, Others), By Technology (Conventional, Advanced, Quantitative, High-throughput, Bioinformatic Analysis), By Type (Expression, Functional, Structural, Computational), By Product (Reagents and Assays, Instruments, Software & Services), By End-User (Pharmaceutical and Biotechnology Companies, Research Institutes, CROs), By Region, Competition, Forecast & Opportunities, 2026F” has evaluated the future growth potential of global proteomics market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges and opportunities in global proteomics market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com